Participants of the MAGIC consortium have participated in the recently concluded ESGCT 2023 conference with poster presentations and talks.
London, July 11, 2023 – We are thrilled to announce the launch of the groundbreaking project “MAGIC” (Next-generation Models And Genetic therapIes for rare neuromusCular diseases). This ambitious four-year initiative jointly funded (~9.5M EUR) by Horizon Europe and UK...
The MAGIC project is an ambitious four-year (2023-2027) initiative jointly funded by Horizon Europe and UK Research and Innovation (UKRI) bringing together 15 international partners to transform the treatment landscape for muscular dystrophies. The primary goal of the...